Free Trial
NYSE:BME

BlackRock Health Sciences Trust (BME) Stock Price, News & Analysis

BlackRock Health Sciences Trust logo
$40.21 -0.25 (-0.62%)
As of 02/21/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About BlackRock Health Sciences Trust Stock (NYSE:BME)

Key Stats

Today's Range
$40.01
$40.33
50-Day Range
$36.92
$41.01
52-Week Range
$36.87
$42.73
Volume
27,483 shs
Average Volume
50,917 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
6.71%
Price Target
N/A
Consensus Rating
N/A

Company Overview

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Receive BME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Health Sciences Trust and its competitors with MarketBeat's FREE daily newsletter.

BME Stock News Headlines

BME And FLC: There Are Still Pockets Of Opportunities
Trump doesn’t give a damn
Porter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met with one of Trump’s longest-serving advisors. We helped put together a plan to help investors capitalize on Trump’s election. And we found out these 10 stocks are the most likely to boom…
BME: 8.4% Yield From An Undervalued Sector
BME: Discount To NAV But High Fees And Volatility
See More Headlines

BME Stock Analysis - Frequently Asked Questions

BlackRock Health Sciences Trust's stock was trading at $37.93 at the beginning of the year. Since then, BME shares have increased by 6.0% and is now trading at $40.21.
View the best growth stocks for 2025 here
.

Top institutional shareholders of BlackRock Health Sciences Trust include Wells Fargo & Company MN, Nova R Wealth Inc., Invesco Ltd. and 1607 Capital Partners LLC.
View institutional ownership trends
.

Shares of BME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BlackRock Health Sciences Trust investors own include Enterprise Products Partners (EPD), Verizon Communications (VZ), Mplx (MPLX), BlackRock Science and Technology Trust (BST), Johnson & Johnson (JNJ), Pfizer (PFE) and Main Street Capital (MAIN).

Company Calendar

Ex-Dividend for 1/31 Dividend
1/15/2025
Dividend Payable
1/31/2025
Ex-Dividend for 2/28 Dividend
2/14/2025
Today
2/22/2025
Dividend Payable
2/28/2025

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
Financial Services
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$55.05 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NYSE:BME) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners